Home > Insider Trading > Filing (0001014108-19-000157)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1337013	Infusystem Holdings Inc	INFU	Surgical & Medical Instruments & Apparatus (3841)	203341405

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519525	R. Christopher Sansone	C/O Infusystem Holdings, Inc. 31700 Research Park Drive Madison Heights MI 48071		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-29	3,328	$4.97	1,456,335	No	4	P	Indirect	See
Common Stock	Acquisiton	2019-08-29	665	$4.97	306,402	No	4	P	Indirect	See
Common Stock	Acquisiton	2019-08-30	8,581	$4.95	1,464,916	No	4	P	Indirect	See
Common Stock	Acquisiton	2019-08-30	1,716	$4.95	308,118	No	4	P	Indirect	See

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See
No	4	P	Indirect	See
No	4	P	Indirect	See
No	4	P	Indirect	See

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	0	Direct

Footnotes

The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.